News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Garay Arpa
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/07/2023 |
4
| Garay Arpa (Chief Commercial Officer) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 2,290 shares
@ $125.7518, valued at
$288k
Exercised 4,562 restricted stock units
@ $0 |
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/02/2023 |
4
| Garay Arpa (Chief Commercial Officer) has filed a Form 4 on Moderna, Inc.|
Txns:
| Granted 20,040 options to buy
@ $138.81, valued at
$2.8M
Granted 5,260 restricted stock units
@ $0 |
|
| 06/29/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Garay Arpa (SVP Human Health Global Mktg.) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 773 shares
@ $87.65, valued at
$67.8k
Paid exercise price by delivering 221 shares
@ $87.65, valued at
$19.4k
Exercised 773 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Garay Arpa (SVP Human Health Global Mktg.) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 866 shares
@ $88.69, valued at
$76.8k
Paid exercise price by delivering 247 shares
@ $88.69, valued at
$21.9k
Exercised 866 restricted stock units
@ $0 |
|
| 03/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|